
    
      Patients with lung cancer who need thoracic radiotherapy will be enrolled in the trial, then
      seprated randomly in two group,the KS injection group treated with chemoradiotherapy plus KS
      injection; the contral group treated with chemoradiotherapy only. After 6 months observation,
      The rates of incidence and the degree of adverse reactions caused by redioterapy; the
      completion rate of radiotherapy; clinical Symptoms; Qof and pulmonary function tests etc.
      will be evaluated.
    
  